| 臺大學術典藏 |
2022-01-24T06:05:33Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang F.-C.; Chen T.W.-W.; Huang T.T.-M.; Lin W.-C.; Liu J.-S.; Chiang W.-C.; Chen Y.-M.; CHIUN HSU; Yeh K.-H.; Chu T.-S. |
| 國立成功大學 |
2022 |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
Kuo, S.-H.;Yeh, K.-H.;Lin, C.-W.;Liou, J.-M.;Wu, M.-S.;Chen, L.-T.;Cheng, A.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:25Z |
Nasal septal tumor as a sole presentation in the head and neck region in Rosai-Dorfman disease
|
Sheen T.-S; Chang Y.-L; Yeh K.-H; Wu C.-T; JENG-YUH KO |
| 臺大學術典藏 |
2021-11-15T07:48:48Z |
Nasal septal tumor as a sole presentation in the head and neck region in Rosai-Dorfman disease
|
Sheen T.-S; Chang Y.-L; Yeh K.-H; Wu C.-T; JENG-YUH KO |
| 臺大學術典藏 |
2021-10-27T03:22:25Z |
Case report: Mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance
|
Chen K.-H.; CHANG-TSU YUAN; Tseng L.-H.; Shun C.-T.; Yeh K.-H. |
| 臺大學術典藏 |
2021-10-27T03:22:15Z |
Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort
|
Chen K.-H.; Lin L.-I.; CHANG-TSU YUAN; Tseng L.-H.; Chao Y.-L.; Liang Y.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-10-04T07:15:55Z |
Panhypopituitarism caused by solitary parasellar metastasis from lung cancer
|
JEN-CHANG KO; Yang P.-C.; Huang T.-S.; Yeh K.-H.; Kuo S.-H.; Luh K.T. |
| 臺大學術典藏 |
2021-09-15T01:20:49Z |
Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver
|
Ho T.-C.; Wang E.-Y.; Yeh K.-H.; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; CHIA-LANG HSU; Chen P.-J.; Yeh S.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-01T02:02:46Z |
An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin [2]
|
Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:45Z |
Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapy
|
Yeh K.H.; ANN-LII CHENG; Tien H.F. |
| 臺大學術典藏 |
2021-09-01T02:02:45Z |
Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid
|
Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:45Z |
Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: A pilot study
|
Yeh K.-H.; ANN-LII CHENG; Chen Y.-C.; Chen B.-R.; Lee W.-J.; Lin J.-T.; Lee P.-H.; Chang K.-J.; Wang C.-H.; Wang T.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:43Z |
Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma
|
ANN-LII CHENG; Chen Y.-C.; Yeh K.-H.; Chuang S.-E.; Chen B.-R.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-01T02:02:42Z |
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers
|
Hsu C.-H.; Yeh K.-H.; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:41Z |
High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy [2]
|
Yeh K.H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:40Z |
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
|
Yeh K.-H.; ANN-LII CHENG; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:40Z |
Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas
|
Yeh K.-H.; ANN-LII CHENG; Su I.H.-J.; Lin M.-T.; Tien H.-F.; Shen M.-C.; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:40Z |
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer
|
Hsu C.; Yeh K.-H.; Hong R.-L.; Yang C.-H.; Lin M.-T.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:39Z |
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung
|
Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:39Z |
Thymic carcinoma with autoimmune syndrome: Successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin
|
Hsu C.-H.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:38Z |
Encephalopathy, lactic acidosis, hyperammonaemia and 5-fluorouracil toxicity (multiple letters) [1]
|
Valik D.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:38Z |
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers
|
Yeh K.-H.; Chen C.-L.; Shun C.-T.; Lin J.-T.; Lee W.-J.; Lee P.-H.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:37Z |
Gastric cancer associated with acute disseminated intravascular coagulation: Successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin
|
Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:37Z |
Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancer
|
Yeh K.-H.; Chen Y.-C.; Yeh S.-H.; Chen C.-P.; Lin J.-T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:37Z |
Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer
|
ANN-LII CHENG; Yeh K.-H.; Lin J.-T.; Hsu C.; Liu M.-Y. |
| 臺大學術典藏 |
2021-09-01T02:02:37Z |
Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen
|
ANN-LII CHENG; Chuang S.-E.; Fine R.L.; Yeh K.-H.; Liao C.-M.; Lay J.-D.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-01T02:02:37Z |
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma
|
ANN-LII CHENG; Yeh K.-H.; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-01T02:02:36Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:36Z |
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocol
|
ANN-LII CHENG; Yeh K.-H.; Uen W.-C.; Hung R.-L.; Liu M.-Y.; Wang C.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:36Z |
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:35Z |
Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma
|
Yeh K.-H.; Lien H.-C.; Hsu S.-M.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:34Z |
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma
|
Yang C.-H.; ANN-LII CHENG; Yeh K.-H.; Yu C.-J.; Lin J.-F.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:34Z |
Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:33Z |
Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil
|
Yeh K.-H.; Yeh S.-H.; Hsu C.-H.; Wang T.-M.; Ma I.-F.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:33Z |
Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil
|
Hsu C.-H.; Yeh K.-H.; Lui L.T.; Lee Y.-C.; Bu C.-F.; Wang H.-P.; Lin J.-T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:32Z |
Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: Direct evidence from colony forming unit- granulocyte and monocyte (CFU-GM) clonogenic assay
|
Yeh K.-H.; Yeh S.-H.; Chang Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:31Z |
Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin
|
Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Chyi Song Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:29Z |
Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma
|
Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; Tang J.-L.; Yeh K.-H.; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-09-01T02:02:27Z |
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation
|
Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; Ea C.-K.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:27Z |
High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; Chang K.-J. |
| 臺大學術典藏 |
2021-09-01T02:02:26Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C.-H.; ANN-LII CHENG; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:24Z |
Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
|
Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:22Z |
Recent advances in therapy for gastric cancer
|
Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:22Z |
Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells
|
Yeh K.-H.; ANN-LII CHENG; Wan J.-P.; Lin C.-S.; Liu C.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:22Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Yeh K.-H.; Lu Y.-S.; Hsiao C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:21Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C.; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:21Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:21Z |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death
|
Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:20Z |
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylation
|
Yeh P.Y.; Yeh K.-H.; Chuang S.-E.; Song Y.C.; ANN-LII CHENG |
